等位基因突變頻率於骨髓化生不良症候群患者之預後意義

李婉瑄 - 2023 - tdr.lib.ntu.edu.tw
… -R could reclassify 8.9% (18/202) of IPSS-R very low/low-risk … 19 % as MDS/AML, MDS with
mutated SF3B1 without excess … follow-up or death from any cause, whichever occurred first. …